Treatment of influenza

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8710024
SERIAL NO

13470154

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a double-stranded RNA which inhibits replication of influenza B viruses by RNA interference, in which the double-stranded RNA comprises an RNA having 19 to 25 nucleotides homologous with a part of an mRNA transcribed from a genomic RNA of the influenza B viruses and an antisense RNA thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KYORIN PHARMACEUTICAL CO LTDCHIYODA-KU

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fujita, Yoshiji Koto-ku, JP 36 198
Kadowaki, Shin-etsu Murayama, JP 2 2
Miyake, Masato Koto-ku, JP 35 217
Nakazawa, Misako Nogi-machi, JP 46 1153
Ueda, Takanori Koto-ku, JP 54 837
Yoshikawa, Tomohiro Koto-ku, JP 22 168

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 29, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00